Response to Gurevich and colleagues: The effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease: a systematic literature review by a European panel of experts
Germain DP, Falissard B, Hilz MJ, Spada M, Wanner C, Elliott PM (2019)
Publication Type: Journal article, Letter
Publication year: 2019
Journal
Book Volume: 20
Article Number: 100493
DOI: 10.1016/j.ymgmr.2019.100493
Authors with CRIS profile
Involved external institutions
Versailles Saint-Quentin-en-Yvelines University / Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)
France (FR)
Universitätsklinikum Würzburg
Germany (DE)
University of Turin / Università degli Studi di Torino (UNITO)
Italy (IT)
University of Paris 11 - Paris-Sud / Université Paris XI Paris-Sud
France (FR)
University College London (UCL)
United Kingdom (GB)
France (FR)
Universitätsklinikum Würzburg
Germany (DE)
University of Turin / Università degli Studi di Torino (UNITO)
Italy (IT)
University of Paris 11 - Paris-Sud / Université Paris XI Paris-Sud
France (FR)
University College London (UCL)
United Kingdom (GB)
How to cite
APA:
Germain, D.P., Falissard, B., Hilz, M.-J., Spada, M., Wanner, C., & Elliott, P.M. (2019). Response to Gurevich and colleagues: The effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease: a systematic literature review by a European panel of experts. Molecular Genetics and Metabolism Reports, 20. https://doi.org/10.1016/j.ymgmr.2019.100493
MLA:
Germain, Dominique P., et al. "Response to Gurevich and colleagues: The effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease: a systematic literature review by a European panel of experts." Molecular Genetics and Metabolism Reports 20 (2019).
BibTeX: Download